This clinical research study is looking at the effect of an investigational medication in
individuals with binge eating disorder. In particular, we are looking for people aged
18 to 55 who have frequent binge episodes.
The study will last 39 weeks in total, during which time you will receive either the
study medication or placebo (sugar pill) once every morning for 34 weeks. The placebo
looks identical to the study medication but contains no active medicine.
Half of the participants in this study will take a placebo and half will take the study
medication. This is so that we can compare outcomes in the two groups at the end
of the study, and determine the effect of the study medication.
Whether you receive the investigational study medication or placebo will be decided
randomly (by chance), and neither you nor the study team will be told to which
treatment you have been assigned.
You will be asked to visit a study clinic every 1 to 2 weeks during the study to allow
us to monitor your health and condition using assessments such as questionnaires,
blood tests, vital sign examinations (e.g., blood pressure) and weight
measurements. These assessments will be provided at no cost.